170 filings
Page 4 of 9
8-K
gq2lnipx 5vnx0
26 Mar 15
Sagent Pharmaceuticals Announces Leadership Changes
12:00am
UPLOAD
y8m9m8doa zpnydimmn
13 Mar 15
Letter from SEC
12:00am
CORRESP
g6eeh3 sx3nvf0v7v
12 Mar 15
Correspondence with SEC
12:00am
CORRESP
bpjm97m
4 Mar 15
Correspondence with SEC
12:00am
8-K
1gcspz sv60y
19 Feb 15
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Results
12:00am
CORRESP
w27 9iiss2z4n
16 Jan 15
Correspondence with SEC
12:00am
8-K
k5i6wzr
12 Jan 15
Statements contained in this presentation contain forward-looking statements that are subject to risks and uncertainties. All
12:00am
CORRESP
ueq0 noqq1tv
22 Dec 14
Correspondence with SEC
12:00am
UPLOAD
ah2vnqkqwsnhl3ak
18 Dec 14
Letter from SEC
12:00am
8-K/A
9iy2 eew782i771z7z
12 Dec 14
Financial Statements and Exhibits
12:00am
EFFECT
inu2p1nt
5 Dec 14
Notice of effectiveness
12:00am
8-K
ye94 hqcq4
19 Nov 14
Other Events
12:00am
8-K
6ucfs2g5wjyjed
4 Nov 14
Sagent Pharmaceuticals Reports Third Quarter 2014 Financial Results
12:00am
8-K
h19o8h2e t00j130di
2 Oct 14
Sagent Pharmaceuticals Announces Acquisition of Omega Laboratories
12:00am
8-K
fmaze84g34
30 Jul 14
Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results
12:00am
8-K
fn1 13vxo
13 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am